UK first country to approve bivalent vaccine

bivalent

First bivalent COVID-19 booster vaccine approved by UK medicines regulator: The adapted COVID-19 vaccine made by Moderna targets two different coronavirus variants – the original virus from 2020 and the Omicron variant. An updated version of the COVID-19 vaccine made by Moderna that targets two coronavirus variants (known as a “bivalent” vaccine) has today been […]

Read More… from UK first country to approve bivalent vaccine

Finnish researchers create nasal COVID vaccine

nasal

Finnish researchers introduce a nasal COVID vaccine: Rokote Laboratories Finland Ltd., a newly-founded academic spin-out based in Finland is working to develop and introduce to the markets a nasal spray vaccine against COVID. The vaccine is based on research carried out at the University of Helsinki and the University of Eastern Finland. The vaccine uses […]

Read More… from Finnish researchers create nasal COVID vaccine

Japan sees increasing adult vaccination uptake rates

Japan

As Japan is still facing the consequences of a winter spike in COVID-19 infections, a new programme of work will seek to design innovative interventions to increase the uptake of vaccinations for people aged 65 and over in Japan. Despite grappling with a flu epidemic in 2019, Japan is still struggling to significantly raise vaccination […]

Read More… from Japan sees increasing adult vaccination uptake rates

Strong support for COVID vaccine in Australia

strong support

Strong support for COVID vaccine; financial stress and mental distress remain high: Australians welcome the COVID-19 vaccine but levels of mental distress and financial stress remain high, particularly among the young, according to the latest Taking the Pulse of the Nation survey. Although Australia is technically no longer in a recession and labour force participation is […]

Read More… from Strong support for COVID vaccine in Australia

Israel’s Rambam Hospital Joins Efforts to Develop Israeli COVID-19 Vaccine

Rambam

Israel’s Rambam Hospital Joins Efforts to Develop Israeli COVID-19 Vaccine: Israel currently has the highest COVID-19 vaccination rate in the world, and the vast majority of Rambam’s approximately 5,300 employees have already received two doses of the Pfizer vaccine. Earlier this month, the Clinical Trials Unit at Rambam Health Care Campus (in Rambam’s Research & Development […]

Read More… from Israel’s Rambam Hospital Joins Efforts to Develop Israeli COVID-19 Vaccine

Sabin Vaccine Institute researchers to investigate COVID-19 misinformation

Sabin Vaccine Institute

Sabin Vaccine Institute Funds Researchers to Investigate COVID-19 Misinformation, Design Solutions to Increase Vaccine Acceptance. The Sabin Vaccine Institute (Sabin) announced this week that it has awarded grants to research teams in four countries to explore the social drivers of COVID-19 misinformation, and its impact on routine immunization acceptance and the acceptance of a COVID-19 […]

Read More… from Sabin Vaccine Institute researchers to investigate COVID-19 misinformation

WHO issues validation for a COVID-19 vaccine

validation for a COVID-19 vaccine

WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access: The World Health Organization (WHO) today listed the Comirnaty COVID-19 mRNA vaccine for emergency use, making the Pfizer/BioNTech vaccine the first to receive emergency validation from WHO since the outbreak began a year ago. The WHO’s Emergency […]

Read More… from WHO issues validation for a COVID-19 vaccine

Less than 50% willing to get a COVID-19 vaccine

willing to get a COVID-19 vaccine

Less than half of people currently willing to get a COVID-19 vaccine, international survey suggests: A new report on the public’s attitudes towards coronavirus vaccines has revealed that around half of those surveyed (51%) may be willing to get vaccinated next year.  Findings from a survey of 13,500 people across 15 countries* in November suggest that […]

Read More… from Less than 50% willing to get a COVID-19 vaccine

Wealthy countries hoarding breakthrough vaccines

countries

AMNESTY INTERNATIONAL: Wealthy countries already hoarding breakthrough vaccines Responding to the announcement by Pfizer-BioNTech that the COVID-19 vaccine it is developing has been found to be effective in 90 percent of people, Tamaryn Nelson, Amnesty International’s Researcher on the Right to Health, said: “It is great news that the Pfizer-BioNTech vaccine is proving effective against […]

Read More… from Wealthy countries hoarding breakthrough vaccines

Never too late to fight back against pandemic

fight back

Never too late to fight back against pandemic: By Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization One million people have now been lost to COVID-19 and many more are suffering because of the pandemic. This milestone is a difficult moment for the world but there are glimmers of hope that encourage us now […]

Read More… from Never too late to fight back against pandemic